nifedipine has been researched along with Breathlessness in 9 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 7.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| "Nifedipine was administered in a dose of 30 mg orally to 14 patients with coronary heart disease and clinical evidence of left heart failure." | 7.66 | [The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)]. ( Beck, OA; Hochrein, H, 1978) |
| "The advantages of long-term administration of vasodilators in the treatment of chronic cor pulmonale were investigated after informed consent in 60 patients with obstructive respiratory insufficiency (56 men, 4 women, mean age 63." | 6.66 | One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease. ( Arnaud, A; Philip-Joet, F; Saadjian, A; Surpas, P; Vestri, R, 1988) |
| "Ten patients with pulmonary hypertension associated with diffuse systemic sclerosis (1 patient), the CREST syndrome (calcinosis cutis, Reynaud's phenomenon, esophageal dysmotility, sclerodactyl, telangiectasia) (6 patients) and mixed connective tissue disease (3 patients) were studied to assess the effect of oral nifedipine on pulmonary and systemic hemodynamics." | 3.68 | Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease. ( Alpert, MA; Lambert, CR; Mukerji, B; Mukerji, V; Panayiotou, H; Pressly, TA; Sharp, GC, 1991) |
| "Nifedipine was administered in a dose of 30 mg orally to 14 patients with coronary heart disease and clinical evidence of left heart failure." | 3.66 | [The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)]. ( Beck, OA; Hochrein, H, 1978) |
| "The advantages of long-term administration of vasodilators in the treatment of chronic cor pulmonale were investigated after informed consent in 60 patients with obstructive respiratory insufficiency (56 men, 4 women, mean age 63." | 2.66 | One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease. ( Arnaud, A; Philip-Joet, F; Saadjian, A; Surpas, P; Vestri, R, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laster, M | 1 |
| Im, D | 1 |
| Ahn, A | 1 |
| Ho, CH | 1 |
| Hodges, R | 1 |
| Barkehall-Thomas, A | 1 |
| Tippett, C | 1 |
| Lenglet, JE | 1 |
| van Geijn, HP | 1 |
| van Schijndel, RJ | 1 |
| Vonk Noordegraaf, A | 1 |
| Bolte, AC | 1 |
| Oei, SG | 1 |
| Van de Water, M | 1 |
| Ariad, S | 1 |
| Hechtlinger, V | 1 |
| Beck, OA | 1 |
| Hochrein, H | 1 |
| Alpert, MA | 1 |
| Pressly, TA | 1 |
| Mukerji, V | 1 |
| Lambert, CR | 1 |
| Mukerji, B | 1 |
| Panayiotou, H | 1 |
| Sharp, GC | 1 |
| Vestri, R | 1 |
| Philip-Joet, F | 1 |
| Surpas, P | 1 |
| Arnaud, A | 1 |
| Saadjian, A | 1 |
| McGill, D | 1 |
| McKenzie, W | 1 |
| McCredie, M | 1 |
2 trials available for nifedipine and Breathlessness
| Article | Year |
|---|---|
One-year clinical study on nifedipine in the treatment of pulmonary hypertension in chronic obstructive lung disease.
Topics: Aged; Clinical Trials as Topic; Dyspnea; Female; Humans; Hypertension, Pulmonary; Lung Diseases, Obs | 1988 |
Comparison of nicardipine and propranolol for chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Double-Blind Metho | 1986 |
7 other studies available for nifedipine and Breathlessness
| Article | Year |
|---|---|
A 12-year-old boy with dyspnea, hypertension, hematuria, and proteinuria.
Topics: Child; Diagnosis, Differential; Dyspnea; Furosemide; Glomerulonephritis; Hematuria; Humans; Hyperten | 2015 |
Maternal hypoxia associated with nifedipine for threatened preterm labour.
Topics: Adult; Dyspnea; Female; Heart Septal Defects, Ventricular; Humans; Hypoxia; Nifedipine; Obstetric La | 2004 |
[Indications for respiratory complications during the use of oral nifedipine as a tocolytic agent, especially in patients with multiple pregnancies].
Topics: Adult; Dyspnea; Female; Humans; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome | 2007 |
[Indications for respiratory complications during the use of oral nifedipine as a tocolytic agent, especially in patients with multiple pregnancies].
Topics: Adrenal Cortex Hormones; Dyspnea; Female; Humans; Lung; Nifedipine; Obstetric Labor, Premature; Preg | 2007 |
Bezafibrate-induced neutropenia.
Topics: Bezafibrate; Dyspnea; Female; Flushing; Humans; Hyperlipidemias; Hypertension; Leukocyte Count; Midd | 1993 |
[The effect of nifedipine on the pulmonary artery pressure in patients with coronary heart disease (author's transl)].
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Dyspnea; Female; Heart Failure; Humans; Mal | 1978 |
Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
Topics: Adult; Blood Pressure; Calcinosis; Cardiac Catheterization; Cardiac Output; Dyspnea; Esophageal Moti | 1991 |